Caliway Biopharmaceuticals Co., Ltd.

NT$64.00As of Sun 8 Nov 2026, 12:00 UTC
TWSE:6919Healthcare
Country Taiwan
PE (Fwd) •••
TSR 4Y CAGR 83.90%
Div yield —
ROE (6.74%)
Biotechnology
Beta (5Y) 1.24
PE TTM —
TSR TTM (57.48%)
Mkt cap NT$99.55B
ROIC (7.58%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$74
16.24%
(91.50%)
Hold 12|2|12|1|1
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.64
0.71
0.76
0.85
1.00%
17.56%
29.85%
34.37%
RevenueNT$B
7.035
6.889
7.057
6.892
11.74%
6.28%
6.91%
1.03%
Peers (US$3.007B)
Cap (US$)
PE
651.0M
354.8x
Capital
TTM
5Y
10Y
Leveragex
1.151
1.257
0.911
EBIT/Intx
1.001
0.197
0.175
Own earn%
1142.98
(23.79)
(26.90)
Sh yield%
31.83
47.70
47.91
Owners
Insiders/Inst%
13.78
25.67
Short interest%
1.04
SBC / revenue%
3.73
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
0–3
$1 testx
—
Incr. ROIC%
0